Get Free Delivery With No Minimum Order




CLARISPRAY MENTHOL NASAL SPRAY 15ML
- Sku : I-033989
Key features
CLARISPRAY Menthol Nasal Spray 15 mL by CLARICARE contains oxymetazoline 0.5 mg/mL as its active ingredient. It is an alpha-adrenergic agonist that produces vasoconstriction of nasal mucosal vessels, reducing swelling and congestion. It provides temporary relief of nasal congestion and sinus pressure associated with the common cold, hay fever, or other upper respiratory allergies. Available over the counter in a 15 mL nasal spray.- Brand: CLARICARE
- Active Ingredient: OXYMETAZOLINE 0.5mg/ml
- Strength: 0.5mg/ml
- Dosage Form: Nasal spray
- Pack Size: 15 ml
- Route: Nasal use
- Prescription Status: OTC
- Drug Class: Alpha-adrenergic agonist (sympathomimetic) nasal decongestant
- Manufacturer: Delpharm Montréal Inc
- Country of Origin: Canada
- SFDA Registration No.: 1307233871
- Shelf Life: 30 months
- Storage: do not store above 30°c
- Symptom Target: Congestion
- Sedating: No
Indications
Approved Uses
Temporary relief of nasal congestion and sinus pressure due to common cold, hay fever, or other upper respiratory allergies.
Off-Label Uses
Adjunct for epistaxis control (topical vasoconstrictor) and to reduce nasal mucosal bleeding during nasal procedures/surgery.
Dosage & Administration
Dosing by Condition
Nasal congestion (adults and children ≥6 years): 2-3 sprays in each nostril every 10-12 hours (typically morning and bedtime); do not exceed 2 doses in 24 hours; use for no more than 3 consecutive days.
Initial Dose
2 sprays per nostril twice daily (morning and evening).
Maintenance Dose
2 sprays per nostril twice daily (morning and evening).
Maximum Dose
Do not exceed 2 doses in 24 hours; limit use to a maximum of 3 consecutive days.
Children's Dosage
Children 2-6 years: 1 spray per nostril twice daily; Children 6-12 years: 1-2 sprays per nostril twice daily; Not recommended under 2 years.
Dose Adjustment Notes
No dose titration/adjustment is generally required; limit use to a maximum of 3 consecutive days to avoid rebound congestion.
How to Take
Blow nose gently; keep head upright (or slightly forward); insert nozzle into one nostril while occluding the other; spray while breathing in gently through the nose; repeat for the other nostril; avoid spraying into eyes; wipe nozzle and replace cap after use.
How to Prepare
Prime the pump before first use (and if not used for several days) by spraying into the air until a fine mist appears; then use as directed.
Side Effects
Common Side Effects
Transient nasal burning/stinging, dryness/irritation, sneezing; headache may occur; rebound congestion (rhinitis medicamentosa) with use beyond 3 days.
Side Effect Frequency
Oxymetazoline 0.5 mg/mL nasal spray: Common (≥1% to <10%): local nasal irritation/burning/stinging, dryness, sneezing. Uncommon (≥0.1% to <1%): headache. Rare (<0.1%): palpitations/tachycardia, increased blood pressure, insomnia/nervousness, dizziness, nausea. Rebound congestion (rhinitis medicamentosa): frequency not reliably quantifiable; risk increases with use >3 days.
Safety & Warnings
Contraindications
Contraindications: hypersensitivity to oxymetazoline/excipients; concomitant use of MAO inhibitors or within 14 days of stopping; atrophic rhinitis (rhinitis sicca).
Warnings & Precautions
Do not use for more than 3 consecutive days; use with caution in hypertension/heart disease, hyperthyroidism, diabetes, and prostatic hypertrophy/urinary retention; avoid eye contact; do not share the spray to reduce infection transmission.
Age Restriction
Not for use in children under 6 years unless directed by a doctor (for 0.05% oxymetazoline nasal spray).
Driving Warning
Safe
Drug Interactions
Drug Interactions
Key interactions: MAO inhibitors (and within 14 days) - risk of severe hypertension; tricyclic antidepressants - enhanced pressor effects; other sympathomimetics/decongestants - additive cardiovascular/CNS effects; caution with antihypertensives and beta-blockers due to potential BP/HR effects.
Interaction Severity
MAJOR: MAO inhibitors (and within 14 days of stopping) due to risk of hypertensive crisis/marked pressor response. MODERATE: Tricyclic antidepressants and other drugs that increase sympathetic tone (e.g., SNRIs/stimulants/other decongestants) may enhance cardiovascular effects. NOTE: Beta-blockers are not a classic major interaction but cardiovascular effects should be monitored in patients on antihypertensives/cardiac drugs.
Food Interaction
No restriction
Alcohol Interaction
Safe
Special Populations
Pregnancy
Consult Doctor
Breastfeeding
Consult Doctor
Children
Children 2-6 years: 1 spray per nostril twice daily; Children 6-12 years: 1-2 sprays per nostril twice daily; Not recommended under 2 years.
Elderly
Use with caution due to increased risk of cardiovascular effects and urinary retention in elderly males with prostatic hypertrophy; standard adult dosing otherwise
Kidney Impairment
No dose adjustment recommended (not applicable/none) for renal impairment when used intranasally as directed.
Liver Impairment
No dose adjustment recommended (not applicable/none) for hepatic impairment when used intranasally as directed.
Storage & Patient Advice
Storage Conditions
do not store above 30°c
Preparation Instructions
Prime the pump before first use (and if not used for several days) by spraying into the air until a fine mist appears; then use as directed.
Missed Dose
Apply as soon as remembered; skip if near next scheduled dose. Do not double the dose.
Stopping the Medicine
Safe to stop at any time; if used longer than 3 days and rebound congestion occurs, discontinue and consider supportive measures (e.g., saline) and seek medical advice if persistent (an intranasal steroid may be used under clinician guidance).
Overdose
Overdose/accidental ingestion (especially in children) may cause CNS depression or agitation, bradycardia or tachycardia, hypertension or hypotension, respiratory depression, and coma; seek urgent medical attention/poison control and provide supportive care.
Patient Counseling
Use only as directed and for ≤3 consecutive days; do not exceed 2 doses/day (q10-12h). Do not share the bottle; avoid eyes. Seek medical advice before use if you have uncontrolled hypertension, significant heart disease, hyperthyroidism, diabetes, or are taking MAOIs/TCAs; stop and seek care if symptoms persist/worsen after 3 days or if palpitations/severe headache occur. Not recommended for children <6 years unless specifically directed by a clinician.
Monitoring Requirements
No routine monitoring
Pharmacology
Mechanism of Action
Alpha-adrenergic agonist (primarily α1 with some α2 activity) causing vasoconstriction of nasal mucosal vessels, reducing edema and nasal congestion.
Onset of Action
Within 5-10 minutes
Duration of Effect
Up to 12 hours.
Half-Life
Approximately 5-6 hours for intravenous administration; intranasal absorption leads to low systemic exposure.
Bioavailability
Systemic absorption is generally low with recommended intranasal use, but clinically meaningful systemic exposure can occur with overuse, mucosal damage, or accidental ingestion (especially in children).
Metabolism
Limited/partial metabolism with a significant fraction excreted unchanged; detailed metabolic pathways are not well characterized in standard OTC references.
Excretion
For any absorbed drug, elimination is mainly renal with some fecal excretion (exact proportions are not well established in routine references).
Protein Binding
Not well established/variable in standard clinical references (do not rely on a specific percentage for routine counseling).
Product Information
Available Dosage Forms
Nasal spray
Composition per Dose
Each spray (approximately 0.1 mL): 0.05 mg oxymetazoline hydrochloride (0.5 mg/mL); with menthol as excipient
Generic Availability
Yes
OTC Alternatives
Xylometazoline nasal spray, saline nasal spray, pseudoephedrine oral decongestant
Symptom Target
Congestion
Sedating
No
Legal Disclaimer - Al Mujtama Pharmacy The product information provided is derived from verified pharmaceutical references and is intended for general health education only. It is not a substitute for professional medical advice, diagnosis, or treatment. Al Mujtama Pharmacy assumes no legal or medical liability for: Any therapeutic decision made based on the information displayed without consulting a licensed physician or pharmacist Any discrepancy between the information provided and the product's package insert or SFDA guidelines Any misuse of medication resulting from personal interpretation of the content displayed Important notice: Drug formulations and instructions may vary between production batches. Always rely on the leaflet included inside the product packaging you have, and consult your pharmacist or physician before starting, adjusting, or discontinuing any medication. By using this content, you acknowledge that you have read this disclaimer and agree that Al Mujtama Pharmacy bears no liability arising from reliance on this information as a substitute for direct medical consultation. Your health is a trust - always consult your doctor first.-1744229570.gif)





